CRMD
Price
$12.37
Change
-$0.43 (-3.36%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
925.65M
62 days until earnings call
XLO
Price
$0.70
Change
-$0.02 (-2.78%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
36.27M
62 days until earnings call
Interact to see
Advertisement

CRMD vs XLO

Header iconCRMD vs XLO Comparison
Open Charts CRMD vs XLOBanner chart's image
CorMedix
Price$12.37
Change-$0.43 (-3.36%)
Volume$132.52K
Capitalization925.65M
Xilio Therapeutics
Price$0.70
Change-$0.02 (-2.78%)
Volume$1.5K
Capitalization36.27M
CRMD vs XLO Comparison Chart in %
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. XLO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and XLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CRMD: $12.80 vs. XLO: $0.72)
Brand notoriety: CRMD and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 146% vs. XLO: 49%
Market capitalization -- CRMD: $1.02B vs. XLO: $37.21M
CRMD [@Biotechnology] is valued at $1.02B. XLO’s [@Biotechnology] market capitalization is $37.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 1 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • CRMD’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRMD is a better buy in the long-term than XLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 6 bullish TA indicator(s).

  • CRMD’s TA Score: 4 bullish, 6 bearish.
  • XLO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, XLO is a better buy in the short-term than CRMD.

Price Growth

CRMD (@Biotechnology) experienced а -10.80% price change this week, while XLO (@Biotechnology) price change was +3.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

CRMD is expected to report earnings on Nov 06, 2025.

XLO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($926M) has a higher market cap than XLO($36.3M). CRMD YTD gains are higher at: 58.025 vs. XLO (-24.817). CRMD has higher annual earnings (EBITDA): 52.3M vs. XLO (-55.02M). CRMD has more cash in the bank: 191M vs. XLO (122M). CRMD has less debt than XLO: CRMD (435K) vs XLO (7.57M). CRMD has higher revenues than XLO: CRMD (121M) vs XLO (15M).
CRMDXLOCRMD / XLO
Capitalization926M36.3M2,551%
EBITDA52.3M-55.02M-95%
Gain YTD58.025-24.817-234%
P/E Ratio16.41N/A-
Revenue121M15M807%
Total Cash191M122M157%
Total Debt435K7.57M6%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
25
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDXLO
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSVNX7.52N/A
N/A
MassMutual Small Company Val R3
RIFYX33.23N/A
N/A
Victory RS Science and Technology Y
MBVKX20.32N/A
N/A
BlackRock Large Cap Focus Value K
AWIIX16.30N/A
N/A
CIBC Atlas Income Opportunities Instl
FIONX16.70N/A
N/A
Fidelity SAI International Index

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-6.57%
MURA - CRMD
38%
Loosely correlated
N/A
ARTL - CRMD
33%
Poorly correlated
-50.34%
RLYB - CRMD
32%
Poorly correlated
+1.47%
XLO - CRMD
31%
Poorly correlated
-0.80%
AXON - CRMD
30%
Poorly correlated
+0.67%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-0.80%
CRMD - XLO
31%
Poorly correlated
-6.57%
AXON - XLO
31%
Poorly correlated
+0.67%
VKTX - XLO
30%
Poorly correlated
-1.12%
AVTX - XLO
27%
Poorly correlated
-3.74%
CBIO - XLO
26%
Poorly correlated
+3.48%
More